Cargando…
Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent. CBD suppresses the development of cancer in both in vitro (cancer cell culture) and in vivo (xenografts in immunodeficient mice) models. For critical evaluation of the a...
Autores principales: | Olivas-Aguirre, Miguel, Torres-López, Liliana, Villatoro-Gómez, Kathya, Perez-Tapia, Sonia Mayra, Pottosin, Igor, Dobrovinskaya, Oxana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951434/ https://www.ncbi.nlm.nih.gov/pubmed/35337163 http://dx.doi.org/10.3390/ph15030366 |
Ejemplares similares
-
Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca(2+) Homeostasis
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021) -
Phenolic Compounds Cannabidiol, Curcumin and Quercetin Cause Mitochondrial Dysfunction and Suppress Acute Lymphoblastic Leukemia Cells
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2020) -
The G-Protein–Coupled Estrogen Receptor Agonist G-1 Inhibits Proliferation and Causes Apoptosis in Leukemia Cell Lines of T Lineage
por: Torres-López, Liliana, et al.
Publicado: (2022) -
Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2019) -
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)